CAS: 705-15-7; 2'-Hydroxy-5'-Methoxyacetophenone

该化合物是替代乙酰苯并酯衍生物,其特点是分别在芳香环的2和5个位置存在氢氧基和甲基苯氧功能组,该化合物是有机合成的多种中间体,特别是在准备药品,香料和精细化学品方面.其结构特征使得选择性反应具有选择性,对构建复杂的分子框架具有价值.氢氧基组提供了一个进一步功能化的场所,而甲氧基组则增加了电密度,影响再活动模式.该化合物显示普通有机溶剂中存在中等溶性,便于在不同反应条件下使用.其定义明确的晶体形式确保了一致性和处理特性.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

4-methoxyphenyl acetate acetic acid 1,4-dimethoxybezene acetyl chloride 4-nitrobenzoic acid 2-acetyl-4-methoxyphenyl ester trans-chalcone2'-hydroxy-5'-methoxy-2,5-bis-methoxymethoxy-trans-chalcone trans-chalcone2'-hydroxy-3,5'-dimethoxy-4-methoxymethoxy-trans-chalcone trans-chalcone2'-hydroxy-5'-methoxy-2-methoxymethoxy-trans-chalcone

合成工艺路线路线简述

    2,5-二羟基苯乙酮置于碘甲烷体系中,用 丙酮 作为反应溶剂,化学反应 12.0H,反应生成 2'-羟基-5'-甲氧基苯乙酮
    参考文献:Chalcones和aurones作为选择性mao-B抑制剂的合成,生物学评估和分子模拟
    标题:Chalcones和aurones作为选择性mao-B抑制剂的合成,生物学评估和分子模拟
    摘要:合成了一系列查耳酮和金酮,并在体外作为单胺氧化酶抑制剂(maoi)进行了评估.我们的结果表明,以前未被报道为maoi的金环是mao-B抑制剂.因此,两个家族选择性地抑制了微摩尔范围内的mao的b同工型,为设计新型和有效的mao抑制剂提供了新颖的支架.借助3D-Qsar和对接研究来表征其活动的主要结构要求.
    DOI:10.1111/cbdd.12458

    海关参考信息

    专利信息


    专利号:US-7741484-B2
    优先权日:2005-09-01
    标 题 :Process for synthesis of phenoxy diaminopyrimidine derivatives
    发明人:CONSTANTINESCU ANTON; GREEN KEENA LYNN; HUMPHREYS ERIC ROY; LEE GARY R; MCGARRY PATRICK FINBAR
    权利人:ROCHE PALO ALTO LLC
    摘要:A method for preparing a compound of formula I n nthe method comprising treating a compound of formula dn n nwith an iodination reagent, to form the compound of formula I, wherein R 1 , R 2 and R 3 are as defined herein.

    专利号:US-9643934-B2
    优先权日:2006-10-04
    标 题:Process for synthesis of phenoxy diaminopyrimidine derivatives
    发明人:DVORAK CHARLES ALOIS; GREEN KEENA LYNN; LEE GARY R
    权利人:ROCHE PALO ALTO LLC
    摘要:A method for preparing a compound of formula k n n n n n n n n n n n n or a salt or solvate thereof,n wherein R 1 is as defined herein, n n the method comprising treating a compound of formula j n n n n n n n n n n n n n n n n or a salt or solvate thereof, n with ammonia, to form the compound of formula k.

    专利号:US-9321804-B2
    优先权日:2011-03-09
    标题 :Synthesis and use of anti-tumor drug LQC-Y
    发明人:LEI HAIMIN
    权利人:UNIV BEIJING CHINESE MEDICINE; 3D MEDICINES LTD
    摘要:Disclosed are the general structural formula of LQC-Y as well as the synthesis and use thereof. Pharmacological experiments demonstrated the marked antitumor effect of such compounds. Single day administration of LQC-Y3 to mice at a maximum dose of 6000 mg/kg showed no toxicity response during the 14-day continuous observation period, indicating the high safety of the compounds, and the compounds can be used to prepare medicaments for preventing and treating carcinomas such as liver cancer, lung cancer. In the general structural formula of LQC-Y, R represents steroid compounds such as cholic acid, deoxycholic acid, ursodeoxycholic acid, chenodeoxycholic acid, and hyodeoxycholic acid and so on; triterpenoid compounds such as oleanolic acid, ursolic acid, pachymic acid, glycyrrhetinic acid and glycosides thereof and so on; emodic acid, emodin and other mono-substituted or poly-substituted structures of anthraquinone parent nucleus; baicalein, baicalin and other flavonoid; shikimic acid, mono-substituted shikimic acid or poly-substituted shikimic acid; gardenia acid and other iridoid acid derivatives; paeonol, curcumin and structural derivatives thereof.

    专利号:US-2007049751-A1
    优先权日:2005-09-01
    标 题 :Process for synthesis of phenoxy diaminopyrimidine derivatives

    专利号:US-8580960-B2
    优先权日:2006-10-04
    标题:Process for synthesis of phenoxy diaminopyrimidine derivatives

    专利号:US-2008086004-A1
    优先权日:2006-10-04
    标题 :Process for synthesis of phenoxy diaminopyrimidine derivatives
    上海蓝润化学有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.longrunchem.com
    企业联系电话:021-69515658;13701998368👤
    📞上海蓝润化学有限公司 ⚠️参考联系方式
    联系人:路小姐
    电话:021-69515658;13701998368
    手机:13701998368
    传真:QQ:819185261
    邮箱:longrunchem@163.com
    通信地址: 上海市青浦区重固镇赵重公路2278号5号楼4层C区34座
    邮编: 201800
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市青浦区重固镇赵重公路2278号5号楼4层C区34座
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Organocatalyzed Kabbe Condensation Reaction For Mild And Expeditious Synthesis Of 2,2‐dialkyl And 2‐spiro‐4‐chromanones
    作者:Naval P. Kapuriya,Jasmin J. Bhalodia,Mrunal A. Ambasana,Rashmi B. Patel,Atul H. Bapodra
    摘要:An Expeditious Kabbe Condensation Reaction For The Synthesis Of 2,2‐dialkyl And 2‐spiro‐chroman‐4(1H)‐ones Has Been Developed Using Pyrrolidine‐butanoic Acid In Dmso As Bifunctional Organocatalyst. Unlike Existing Methods, This Reaction Proceeds At Room Temperature With High Yields, Rendering It An Attractive Method To Synthesize A Vast Variety Of Privileged 4‐chromones.

    合成参考文献


    摘要:Kwiecień, H., Science of Synthesis Knowledge Updates, (2014) 4, 114.
    摘要:Dong, X.; Liu , H., Science of Synthesis Knowledge Updates, (2019) 3, .
    摘要:Wu, F.; Zhu, S., Science of Synthesis Knowledge Updates, (2020) 1, 171.
    摘要:Kleemann A., Kutscher B., Reichert D., Bossart M., Pharmaceutical Substances, Thieme [Online], Stuttgart, (2025).
    参考文献:10.1107/s1600536810035816
    摘要:Jasinski JP, Pek AE, Narayana B, Yathirajan HS, Nayak PS. 2-(4-Chloro-phen-yl)-6-meth-oxy-chroman-4-one. Acta Crystallogr Sect E Struct Rep Online. 2010 Sep 11;66(Pt 10):o2546–7.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知